Description

Chronic liver disease (CLD) causes 1.8% of all deaths in Europe. Without policies to mitigate harmful alcohol consumption and obesity, that proportion will continue to increase. In order to address this, EASL commissioned the Hepahealth II study, a validated and peer-reviewed miscrosimulation model, to project the impact of various policy scenarios designed to improve liver health in Europe. In this episode, Professors Maria Buti, Shira Zelber-Sagi, and Peter Jepsen introduce the study, its aims, and results. Finally, Alice Chapman-Hatchett discusses more broadly the policy situation in Europe and the challenges to implementing more health focused policies.

The Hepahealth II study has been supported by an unrestricted education grant from Bristol-Myers Squibb and Gilead. Bristol-Myers Squibb and Gilead have had no input into EASL content.

 

Speakers

  
maria buti

Maria Buti is currently Professor of Medicine and consultant of Hepatology at the Hospital General Universitari Valle Hebron, Barcelona and the EASL Public Health Councillor. Dr Buti has worked in viral hepatitis for the last 35 years, particularly in diagnosis and therapy of hepatitis B , C and D. She has published more than 500 papers the field of liver disease, with numerous papers and contributions to books.
Shira Zelber-Sagi

Prof. Zelber-Sagi is a clinical dietitian, Epidemiologist, and researcher in nutritional and lifestyle epidemiology, chronic diseases related to lifestyle, and public health aspects. Graduated BSc in nutrition sciences at the Hebrew University. Graduated with a Ph.D. in Epidemiology and Preventive Medicine at the Sackler School of Medicine at Tel Aviv University. Currently, she is a full Professor and Head of the School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa. She is a member of the “National Committee for Nutrition, Gastroenterology, and Liver Disease”. Since June 2023, she has been an EASL Governing Board member and Public Health Councillor-elect. She is a United European Gastroenterology (UEG) Policy and Public Health Committee member, and the founder of the Gastroenterology and Hepatology Dietitians’ forum within the Israeli Dietitians Association. She has published over 150 scientific publications, mostly dealing with lifestyle and liver disease and other chronic diseases, including nutrition, physical activity, smoking, alcohol, and policy recommendations. Email: [email protected]

Peter Jepsen

Prof. Peter Jepsen is an EASL Policy and Public Health Committee Member. Born in 1975, graduated from the medical school in Aarhus, Denmark in 2003. Since then clinical training and specialisation in hepatology, alongside training in clinical epidemiology. Prof. Jepsen has published more than 100 papers, most of them in the field of hepato-epidemiology. He currently does half-time clinical work, half-time research. Prof. Jepsen's primary interests are alcoholic liver disease and hepatocellular carcinoma, most notably the value of surveillance for hepatocellular carcinoma among patients with alcoholic cirrhosis.
Alice Chapman-Hatchett

Alice Chapman-Hatchett is the Director of the Health and Europe Centre, a social enterprise in the National Health Service in the UK. The Centre works to bring European learning, practice, and policy to the local health community, improving patient outcomes and focusing on health inequalities and social determinants of health. Chapman is President of EPHA (European Public Health Alliance) and has over 13 years of experience working in public health in areas ranging from sexual health, NCDs, ageing, mental health, and health systems.

Log in to post comments